Jeil Pharmaceutical Holding Overview
- Year Founded
-
1959
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
002620
- Investments
-
3
- Share Price
-
$4.97
- (As of Friday Closing)
Jeil Pharmaceutical Holding General Information
Description
Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.
Contact Information
Website
www.jeilph.co.krCorporate Office
- 343 Sapyeong-daero
- Seocho-gu
- Seoul, 06543
- South Korea
Corporate Office
- 343 Sapyeong-daero
- Seocho-gu
- Seoul, 06543
- South Korea
Jeil Pharmaceutical Holding Stock Performance
As of 20-Nov-2026, Jeil Pharmaceutical Holding’s stock price is $4.97. Its current market cap is $76.2M with 15.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.97 | $5.11 | $3.98 - $6.82 | $76.2M | 15.4M | 4.58K | $0.38 |
Jeil Pharmaceutical Holding Financials Summary
As of 30-Jun-2026, Jeil Pharmaceutical Holding has a trailing 12-month revenue of $435M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 218,879 | 252,643 | 222,500 | 291,099 |
| Revenue | 434,721 | 462,088 | 571,534 | 614,971 |
| EBITDA | 31,226 | 42,071 | (29,566) | 5,748 |
| Net Income | 5,812 | 10,284 | (37,495) | (12,429) |
| Total Assets | 577,938 | 608,791 | 604,515 | 682,867 |
| Total Debt | 119,726 | 116,228 | 105,373 | 123,565 |
Jeil Pharmaceutical Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jeil Pharmaceutical Holding Signals
Jeil Pharmaceutical Holding Investments (3)
Jeil Pharmaceutical Holding’s most recent deal was a Later Stage VC with Autotelic Bio for . The deal was made on 14-Dec-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Autotelic Bio | 14-Dec-2020 | Later Stage VC | Drug Discovery | ||
| Chongqing JeilYao Pharma | 25-Sep-2013 | Joint Venture | Pharmaceuticals | ||
| Kyowa Hakko Kirin Korea | 24-May-1991 | Joint Venture | Pharmaceuticals |
Jeil Pharmaceutical Holding ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Jeil Pharmaceutical Holding Exits (1)
Jeil Pharmaceutical Holding’s most recent exit was on 24-May-1991 from Kyowa Hakko Kirin Korea. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Kyowa Hakko Kirin Korea | 24-May-1991 | Completed |
|
Jeil Pharmaceutical Holding FAQs
-
When was Jeil Pharmaceutical Holding founded?
Jeil Pharmaceutical Holding was founded in 1959.
-
Where is Jeil Pharmaceutical Holding headquartered?
Jeil Pharmaceutical Holding is headquartered in Seoul, South Korea.
-
What is the size of Jeil Pharmaceutical Holding?
Jeil Pharmaceutical Holding has 38 total employees.
-
What industry is Jeil Pharmaceutical Holding in?
Jeil Pharmaceutical Holding’s primary industry is Holding Companies.
-
Is Jeil Pharmaceutical Holding a private or public company?
Jeil Pharmaceutical Holding is a Public company.
-
What is Jeil Pharmaceutical Holding’s stock symbol?
The ticker symbol for Jeil Pharmaceutical Holding is 002620.
-
What is the current stock price of Jeil Pharmaceutical Holding?
As of 20-Nov-2026 the stock price of Jeil Pharmaceutical Holding is $4.97.
-
What is the current market cap of Jeil Pharmaceutical Holding?
The current market capitalization of Jeil Pharmaceutical Holding is $76.2M.
-
What is Jeil Pharmaceutical Holding’s current revenue?
The trailing twelve month revenue for Jeil Pharmaceutical Holding is $435M.
-
What is Jeil Pharmaceutical Holding’s annual earnings per share (EPS)?
Jeil Pharmaceutical Holding’s EPS for 12 months was $0.38.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process